CORPORATE OVERVIEW (PDF Version -download)

Progenitor Cell Therapy is a client-based cell therapy services company that supports the development of cellular therapies by providing cGMP-compliant cell manufacturing and consulting services that address regulatory, financial, technical, process, and quality systems strategies. PCT's cG(x)P nationwide network enables it to provide a full spectrum of support including preclinical development, clinical research, collection, processing, tissue storage, diagnostics/biologic product testing, manufacturing, distribution and transportation.

ESTABLISHED: 1997

FINANCIAL: Privately held

WEBSITE: http://www.progenitorcelltherapy.com

PROFILES: LinkedIn: www.linkedin.com/in/progenitorcelltherapy | Twitter: @PCTcorp

CONTACT:
Progenitor Cell Therapy, LLC
4 Pearl Court, Allendale, NJ 07401

Telephone: 201. 883.5300
Fax: 201. 883.1409
info@progenitorcelltherapy.com

LOCATIONS:
Headquarters - Corporate
4 Pearl Court, Allendale, NJ 07401 USA

East Coast Manufacturing
20 Prospect Ave, Hackensack NJ & 4 Pearl Court, Allendale, New Jersey

East Coast R&D
30 Prospect Avenue - 4th Floor, David Joseph Jurist Research Building, Hackensack, New Jersey

West Coast Manufacturing and R&D
291 N. Bernardo Avenue, Mountain View, California

MANAGEMENT TEAM:
Andrew L. Pecora, M.D., F.A.C.P.
Chairman, Chief Executive Officer and Chief Medical Officer, Member of Board of Managers

Robert A. Preti, Ph.D.
President and Chief Scientific Officer, Member of Board of Managers

John P. Gandolfo
Chief Financial Officer

George S. Goldberger
Chief Business Officer

Daryl LaSueur
Vice President of Manufacturing Operations

Wai Shun Chan, Ph.D.
Scientific Director

Marie DeVito, M.Sc.
Senior Director of Quality Assurance and Quality Control

Marta Schilling, B.Sc.
Technical Director - Projects (West Coast)

MARKET OVERVIEW
Progenitor Cell Therapy, LLC services are applicable throughout the entire field of cell therapy. The cell therapy market is experiencing rapid growth, and according to industry reports, the value of the 2005's international cell therapy market was estimated to be $26.6 billion. It has been projected that the market will reach $56.2 billion in 2010 and $96.3 billion in 2015*.

* Cell Therapy-Technologies, Markets, and Companies